HomeCompareSHAC vs JNJ

SHAC vs JNJ: Dividend Comparison 2026

SHAC yields 19.85% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHAC wins by $52.3K in total portfolio value
10 years
SHAC
SHAC
● Live price
19.85%
Share price
$10.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.3K
Annual income
$6,630.14
Full SHAC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SHAC vs JNJ

📍 SHAC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHACJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHAC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHAC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHAC
Annual income on $10K today (after 15% tax)
$1,687.06/yr
After 10yr DRIP, annual income (after tax)
$5,635.62/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SHAC beats the other by $4,932.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHAC + JNJ for your $10,000?

SHAC: 50%JNJ: 50%
100% JNJ50/50100% SHAC
Portfolio after 10yr
$46.2K
Annual income
$3,728.96/yr
Blended yield
8.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SHAC
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHAC buys
0
JNJ buys
0
No recent congressional trades found for SHAC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHACJNJ
Forward yield19.85%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$72.3K$20.0K
Annual income after 10y$6,630.14$827.78
Total dividends collected$41.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SHAC vs JNJ ($10,000, DRIP)

YearSHAC PortfolioSHAC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,685$1,984.78$10,676$355.77+$2.0KSHAC
2$15,926$2,352.94$11,407$389.39+$4.5KSHAC
3$19,801$2,760.84$12,198$426.53+$7.6KSHAC
4$24,396$3,208.14$13,056$467.62+$11.3KSHAC
5$29,797$3,693.91$13,987$513.12+$15.8KSHAC
6$36,100$4,216.65$14,998$563.56+$21.1KSHAC
7$43,401$4,774.31$16,098$619.52+$27.3KSHAC
8$51,803$5,364.43$17,295$681.69+$34.5KSHAC
9$61,414$5,984.10$18,599$750.82+$42.8KSHAC
10$72,343$6,630.14$20,022$827.78+$52.3KSHAC

SHAC vs JNJ: Complete Analysis 2026

SHACStock

SCP & CO Healthcare Acquisition Company does not have significant business. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to identify a prospective target business in the healthcare technology or healthcare-related platform in the United States and other developed countries. The company was incorporated in 2020 and is based in Tampa, Florida.

Full SHAC Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SHAC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHAC vs SCHDSHAC vs JEPISHAC vs OSHAC vs KOSHAC vs MAINSHAC vs ABBVSHAC vs MRKSHAC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.